The main distinguishing feature of the Regulation is flexibility in the regulation of state purchases of medical devices. In the text of the Regulation clearly spelled out the conditions for restricting the admission of imported medical devices, including laboratory, to public procurement – the presence of at least two companies that offer domestic (originating from the countries of the Eurasian Economic Union) of the medical device, its characteristics meet the customer's specifications. The new rules will impact more than 25% of the market of medical products in monetary terms (as of 2015), slightly changing the balance of power among the key manufacturers and suppliers. Moreover, even within the designated market share changes will be of a more decorative in nature and will only lead to a partial redistribution of orders in favor of domestic producers.